# Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rivaroxaban-vs-warfarin-and-renal-outcomes-in-non-valvular-atrial-fibrillation/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Adrían V. Hernández,G. Bradley,Mohammad Khan,Andrew J Fratoni,Anna Gasparini,Yuani M. Roman,Thomas J. Bunz,Daniel Eriksson,Anna‐Katharina Meinecke,Craig I Coleman |
| Citations | 67 |
| DOI | 10.1093/ehjqcco/qcz047 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2969872798 |
| PMID | 31432074 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Daniel Eriksson](https://scholariq.org/researchers/daniel-eriksson/)

## Paper journal

- [European Heart Journal - Quality of Care and Clinical Outcomes](https://scholariq.org/journals/european-heart-journal-quality-of-care-and-clinical-outcomes/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.